Related Experiment Videos
Interleukin 3 activates human blood basophils via high-affinity binding sites
Summary
Recombinant human interleukin-3 (rhIL-3) binds to a specific receptor on human basophils, influencing their function. This cytokine acts as a regulator of basophil activity, impacting histamine release and proliferation.
Area of Science:
- Immunology
- Hematology
Background:
- Basophils play a crucial role in immune responses.
- Understanding the regulation of basophil function is vital for immunological research.
Purpose of the Study:
- To investigate the binding of recombinant human interleukin-3 (rhIL-3) to human basophils.
- To determine if rhIL-3 modulates basophil function.
Main Methods:
- Isolation of pure human basophils from chronic myeloid leukemia (CML) blood using negative selection.
- Radioligand binding assays with 125I-radiolabeled rhIL-3 and Scatchard plot analysis.
- Assessment of [3H]thymidine incorporation and histamine release assays.
Main Results:
- Specific, high-affinity binding sites for rhIL-3 were identified on purified basophils.
- rhIL-3 significantly increased [3H]thymidine incorporation in CML basophils.
- rhIL-3 enhanced histamine release from normal blood basophils upon anti-IgE stimulation.
Conclusions:
- rhIL-3 binds to a specific receptor on human blood basophils.
- rhIL-3 acts as a potent regulator of basophil function, including proliferation and mediator release.